The U.S.

Telomir Pharmaceuticals has released new preclini

NRG Therapeutics has closed an oversubscribed £5

A new real-world analysis by Omada Health finds t

Biomed Industries will present results from its P

C2N Diagnostics announced it has secured a $1 mil

Turn Biotechnologies, a California-based company

Mountain View, CA – Google has established a ne

Life Biosciences has in‑licensed intellectual p

C2N Diagnostics has widened the intended use of i

PhysioAge Health Analytics CEO on using biomarke

Anderson Longevity Clinic expands with new franch

Immunis Inc.

BioAge, a Richmond, California–based biotechnol

Aspen Neuroscience has completed dose escalation

Haya Therapeutics, a biotech firm pioneering prec

Revalia Bio lands funding to scale up drug testi

Investment from Allen Law’s Seveno Capital ref

With a platform designed to preserve mitochondri

Renue By Science has introduced Renue Blue Face C

Winona has introduced a comprehensive 2025 telehe

Biomarkers of Aging Conference 2025 convenes lea

UC San Diego team shows spaceflight drives hallm

Healthspan innovator Niko Hems discusses why big

Anderson Longevity Clinic has sold a franchised u

Beijing parade produces unexpected aside as Chin

High fiber diet improved frailty in Alzheimer’

MBX Biosciences, a clinical-stage biopharmaceutic

Beacon Therapeutics has released interim nine-mon

LifeVantage Corporation has entered a definitive

Salt Lake City – Clene Inc.

Cognition Therapeutics, a clinical-stage company

Company’s cell manufacturing platform to power

Two-day summit seeks to accelerate the integrati

Cumulus Neuroscience announced new research showi

Haut.

ProMIS Neurosciences reported that its independen

C2N Diagnostics is set to relocate and expand its

AbbVie has released updated findings from the Pha

Wonderfeel, a longevity-focused wellness bioscien

Collaboration centers on gene silencing therapy

Novo Nordisk reports weight-loss drug cut the co

Nanoscope Therapeutics has achieved significant r

Citryll has successfully dosed the first patient

Countdown for a Cure provides grant to advance d

Doyle Lokitiyakul, Communications Lead of Public

Alnylam Pharmaceuticals reported new data from it

ProHealth Longevity has introduced a pharmaceutic

Alnylam and its partner Roche will initiate a glo

Immortal Dragons, a US$40 million purpose-driven